BRAF, which is well-known in cancer, as it is a major target of genetic mutations in tumorigenesis, has the highest activity among three isoforms, likely by virtue of its constitutively-phosphorylated NTA motif [75,80]. The gene discussed is BRAF; the disease is cancer.